-CEO and directors buying in at 7.5 cents this Thursday
-6 million in cash and 4 million in rebates coming in (10 million in funding)
- drug developed and de risked over the past 4 years
- Target market 55 billion dollars
- Peers in same space 70-100 million market caps after pre clinical success
- 3 months away from first in human dose
- Backed by the Us defence department and de risked on current study from 2010
Worth the same as its finding funny. Keep dumping apparently there is no potential.
- Forums
- ASX - By Stock
- Ann: Nyrada Commences Walter Reed Traumatic Brain Injury Study
-CEO and directors buying in at 7.5 cents this Thursday -6...
-
- There are more pages in this discussion • 109 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NYR (ASX) to my watchlist
|
|||||
Last
6.3¢ |
Change
0.001(1.61%) |
Mkt cap ! $11.47M |
Open | High | Low | Value | Volume |
6.4¢ | 6.4¢ | 5.9¢ | $6.601K | 108.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2018 | 6.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.5¢ | 9000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2018 | 0.063 |
1 | 45000 | 0.061 |
2 | 26453 | 0.059 |
1 | 5000 | 0.058 |
1 | 15000 | 0.057 |
Price($) | Vol. | No. |
---|---|---|
0.065 | 9000 | 1 |
0.069 | 33333 | 1 |
0.070 | 17666 | 2 |
0.079 | 50000 | 1 |
0.080 | 50000 | 1 |
Last trade - 15.16pm 04/07/2024 (20 minute delay) ? |
Featured News
NYR (ASX) Chart |